Please join infectious disease experts Dr. Erica Ollmann Saphire and Dr. Sujan Shresta as they report on their latest COVID-19 research live from the lab on Tuesday, November 24 from 12:00 – 1:00 p.m. (PST).
Dr. Ollmann Saphire has earned high acclaim for directing an international coalition that was instrumental in guiding the development of the first FDA-approved treatment for Ebola virus. During the webinar, Dr. Saphire will update the audience on the latest COVID-19 research results obtained in her lab as well as recent progress made by CoVIC, a global alliance modeled after the successful Ebola team and geared toward finding therapeutic antibodies to treat COVID-19.
Dr. Shresta’s research upended established dogma when she showed that dengue and Zika vaccines designed to mainly induce an antibody response can make subsequent infections with these viruses much worse. Dr. Shresta will discuss her insights into the importance of eliciting T cells to work alongside antibodies to prevent potentially devasting consequences and how her lab is applying these findings to designing a safe and effective COVID-19 vaccine.
Questions for Drs. Saphire and Shresta can be submitted prior to the webinar by emailing Engagement and Stewardship Officer Chelsea Luedeke at email@example.com. We will make every effort to answer as many questions as possible during the webinar.
Additional information on current COVID-19 research efforts underway can be found at: lji.org/covid-19